This was the stock's second consecutive day of losses.

Shares of GE HealthCare Technologies Inc. GEHC slipped 2.10% to $83.79 Wednesday, on what proved to be an all-around mixed ...

Goldman Sachs upgraded GE HealthCare (GEHC) to Buy from Neutral with a price target of $100, up from $85. The firm’s confidence in the outlook ...

Learn more about whether GE HealthCare Technologies Inc. or Insulet Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The Goldman Sachs Group upgraded shares of GE HealthCare Technologies (NASDAQ:GEHC – Free Report) from a neutral rating to a buy rating in a research note published on Tuesday morning, MarketBeat ...

Fintel reports that on March 11, 2025, Goldman Sachs upgraded their outlook for GE HealthCare Technologies (NasdaqGS:GEHC) ...

Goldman Sachs upgrades GE Healthcare to Buy, raising its price target to $100, as analysts see market stabilization and China ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $104.0, a high estimate of $110.00, and a low estimate of $100.00. Observing a 9.76 ...

The Cincinnati-based company noted Jake Phillips' work beefing up compliance and regulatory programs and resolving ...

Analysts have been eager to weigh in on the NA sector with new ratings on GE Vernova Inc. (GEV – Research Report) and Solventum Corporation ...

GE HealthCare's Responsible AI Principles are designed so that AI systems we engage or develop meet the highest standards of performance, safety, and accountability.